Search results
Showing 166 to 171 of 171 results for leukaemia
People with a rare blood disorder have access to a new treatment following draft guidance from NICE.
More than 1,000 people each year will benefit from NICE's recommendation.
Chemotherapy-free treatment option to be offered to patients with England's most common leukaemia
Acalabrutinib, taken as a twice daily tablet, is recommended as an option for adults with untreated chronic lymphocytic leukaemia.
NICE recommends two CAR-T therapies, both given as one-off infusions, to treat aggressive forms of blood cancer.
New option for adult leukaemia patients as we recommend treatment
Today we've recommended an immunotherapy treatment that could prevent blood cancer from returning in adults who've responded well to initial therapy.
Innovative CAR-T therapy recommended to treat an aggressive form of leukaemia.